Literature DB >> 9796986

Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.

D K Frank1, M J Frederick, T J Liu, G L Clayman.   

Abstract

In models of human lung and head and neck cancer, there have been anecdotal reports of a bystander effect in wild-type p53 gene therapy, an apoptosis-inducing molecular intervention strategy. These reports do not definitively demonstrate the presence of a bystander effect, nor do they elucidate requirements for or characteristics of this phenomenon. We have investigated human squamous cell carcinoma of the head and neck for the presence and requirements of a bystander effect after wild-type p53 gene transduction. Recombinant adenovirus, Ad-p53, was used for wild-type p53 gene transfers. To investigate the role of intercellular contact between p53-transduced and nontransduced cells in mediating a growth inhibitory (bystander) effect on nontransduced cells, coculturing experiments were conducted on human squamous cell carcinoma of the head and neck cell lines TU138 and TU167. For TU138, 29% growth inhibition of nontransduced cells was demonstrated 3 days after p53-transduced and nontransduced cells were cocultured with intercellular contact. This growth inhibition was abolished when cells were cocultured without intercellular contact. TU167 did not demonstrate a bystander effect under any coculturing condition. Supernatant from Ad-p53-infected TU138 and TU167 cells demonstrated no growth-inhibitory effect on respective nontransduced cells. The bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of squamous cell carcinoma of the head and neck, when present, requires intercellular contact. Possible mechanisms of the observed in vitro bystander effect are discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9796986

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  4 in total

Review 1.  Local delivery for gene therapy.

Authors:  G L Clayman; L Dreiling
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

2.  Adenovirus expressing mutant p27kip1 enhanced apoptosis and inhibited the growth of xenografted human breast cancer.

Authors:  Tsuyoshi Sasaki; Yu Katayose; Kuniharu Yamamoto; Masamichi Mizuma; Satoru Shiraso; Shinichi Yabuuchi; Akira Oda; Toshiki Rikiyama; Masaya Oikawa; Toru Onogawa; Masanori Suzuki; Choon-Taek Lee; Michiaki Unno
Journal:  Surg Today       Date:  2007-11-26       Impact factor: 2.549

Review 3.  [The use of p53 as a tool for human cancer therapy].

Authors:  V P Almazov; D V Kochetkov; P M Chumakov
Journal:  Mol Biol (Mosk)       Date:  2007 Nov-Dec

Review 4.  Liver-targeted gene therapy: Approaches and challenges.

Authors:  Rajagopal N Aravalli; John D Belcher; Clifford J Steer
Journal:  Liver Transpl       Date:  2015-06       Impact factor: 6.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.